Ionic dissolution products of NovaBone® promote osteoblastic proliferation via influences on the cell cycle

Journal of International Medical Research

Volumn 37, Issue 3, 2009, Pages 737-745

  Qiu, Z ^a   Yang, Huilin ^a   Wu, J ^a   Wei, L ^a   Li, J ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Bioactive materials; Bone loss; Cell cycle; MG63 osteoblast like cells; NovaBone ; Osteoblasts; Proliferation

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; SILICON; BIOGLASS; ION;

ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOLUTION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; ANIMAL; CELL COUNT; CELL CYCLE; CELL SURVIVAL; CERAMICS; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; SOLUBILITY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CERAMICS; CULTURE MEDIA, CONDITIONED; IONS; MICE; OSTEOBLASTS; SOLUBILITY;

EID: 70349249536     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700317     Document Type: Article

References (23)

1. Asselmeier M, Caspari RB, Bottenfield S: A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med 1993; 21: 170-175. (Pubitemid 23096794)
2. Kwong LM, Jasty M, Harris WH: High failure rate of bulk femoral head allografts in total hip acetabular reconstructions at 10 years. J Arthroplasty 1993; 8: 341-346. (Pubitemid 23246167)
3. Shinar AA, Harris WH: Bulk structural autogenous grafts and allografts for reconstruction of the acetabulum in total hip arthroplasty. Sixteen-year-average follow-up. J Bone Joint Surg Am 1997; 79: 159-168.
4. Loty C, Sautier JM, Tan MT, et al: Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation. J Bone Miner Res 2001; 16: 231-239. (Pubitemid 32105404)
5. So K, Fujibayashi S, Neo M, et al: Accelerated degradation and improved bone-bonding ability of hydroxyapatite ceramics by the addition of glass. Biomaterials 2006; 27: 4738-4744. (Pubitemid 43849983)
6. Salinas AJ, Vallet-Regí M, Izquierdo-Barba I: Biomimetic apatite deposition on calcium silicate gel glasses. J Sol-Gel Sci Technol 2001; 21: 13-25. (Pubitemid 32512178)
7. Oonishi H, Hench LL, Wilson J, et al: Quantitative comparison of bone growth behavior in granules of Bioglass®, A-W glass-ceramic, and hydroxyapatite. Biomed Mater Res 2000; 51: 37-46. (Pubitemid 30331980)
8. Kokubo T: Surface chemistry of bioactive glass-ceramics. J Non-Cryst Solids 1990; 120: 138-151.
9. Hench LL, West JK: Biological applications of bioactive glasses. Life Chem Rep 1996; 13: 187-241.
10. 1-phase of the on-going cell cycle. J Cell Biochem 2003; 90: 244-252.
11. Xynos ID, Hukkanen MVJ, Batten JJ, et al: Bioglass® 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tiss Int 2000; 67: 321-329.
12. Xynos ID, Edgar AJ, Buttery LD, et al: Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000; 276: 461-465.
13. Sun JY, Yang YS, Zhong JP, et al: The effect of the ionic products of Bioglass® dissolution on human osteoblasts growth cycle in vitro. J Tiss Eng Regen Med 2007; 1: 281-286 .
14. Gough GE, Jones JR, Hench LL: Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004; 25: 2039-2046.
15. Christodoulou I, Buttery LD, Tai G, et al: Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J Biomed Mater Res Part B: Appl Biomater 2006; 77: 431-446. (Pubitemid 43670333)
16. Xynos ID, Edgar AJ, Buttery LD, et al: Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J Biomed Mater Res 2001; 55: 151-157.
17. Reffitt DM, Ogston N, Jugdaohsingh R, et al: Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 2003; 32: 127-135. (Pubitemid 36299140)
18. 2 gel-glasses for biomedical applications. Biomed Mater Eng 2004; 14: 467-486.
19. Kuzushima M, Mogi M, Togari A: Cytokine-induced nitric-oxide-dependent apoptosis in mouse osteoblastic cells: Involvement of p38MAP kinase. Arch Oral Biol 2006; 51: 1048-1053. (Pubitemid 44442099)
20. 1 calcium signaling increases α5 integrin expression in osteoblasts. J Orthop Res 2002; 20: 1042-1049.
21. Keeting PE, Oursler MJ, Wiegand KE, et al: Zeolite A increases proliferation, differentiation, and transforming growth factor beta production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res 1992; 7: 1281-1289.
22. Gao TJ, Aro HT, Ylanen H, et al: Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro. Biomaterials 2001; 22: 1475-1483. (Pubitemid 32573665)
23. Tsuji K, Bandyopadhyay A, Harfe BD, et al: BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006; 38: 1424-1429. (Pubitemid 44837565)